论文信息 - Clinical Outcomes of Enzalutamide in Metastatic Hormone-sensitive Prostate Cancer in Patients Aged <75 and ≥75 Years: ARCHES Post Hoc Analysis. - 字舞流文

Clinical Outcomes of Enzalutamide in Metastatic Hormone-sensitive Prostate Cancer in Patients Aged <75 and ≥75 Years: ARCHES Post Hoc Analysis.

R. Szmulewitz | T. Iguchi | F. Gómez‐Veiga | Arnulf Stenzl | A. Villers | Jeffrey Holzbeierlein | G.P. Haas | Neal D. Shore | Arun A. Azad | Boris Alekseev | Antonio Alcaraz | Andrew J. Armstrong | B. Rosbrook | F. Zohren | Jie Ma | A. J. Armstrong